🇺🇸 FDA
Patent

US 10822340

Substituted imidazolopyrazine compounds and methods of using same

granted A61PA61P1/16A61P11/00

Quick answer

US patent 10822340 (Substituted imidazolopyrazine compounds and methods of using same) held by The Regents of the University of California expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61P, A61P1/16, A61P11/00, A61P21/00, A61P25/00